Inventor(s)

AnonymousFollow

Abstract

Abstract:

The present invention relates to a novel process for the preparation of (R)-3-(4-(7H-pyrrolo[2,3­d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile or a salt thereof, which is referred to as Ruxolitinib and represented by the following structural formulae,

Formula-1

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS